Access cutting-edge palmoplantar pustulosis treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access palmoplantar pustulosis specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related palmoplantar pustulosis treatment provided free
The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in the treatment of adult participants with mild to severe palmoplantar pustulosis (PPP). Total study duration for each participants will be approximately 18 weeks, for an approximate total of 9 visits.
Sponsor: LEO Pharma
Check if you qualify for this palmoplantar pustulosis clinical trial in Philadelphia, PA
If you're searching for palmoplantar pustulosis treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced palmoplantar pustulosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.